Seckler B, Rando R R
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Biochem J. 1989 Dec 1;264(2):489-93. doi: 10.1042/bj2640489.
The absorption of light by rhodopsin leads to the formation of an activated intermediate (R*) capable of catalysing the exchange of GTP for GDP in a retinal guanine-nucleotide-binding regulatory protein (transducin). The ability of R* to function as a catalyst is terminated by the rhodopsin kinase. The 10 nonactive-site lysine residues of rhodopsin can be reductively dimethylated to form permethylated rhodopsin (PMRh). This derivative is phosphorylated to the same extent as rhodopsin after photolysis. The monomethylation of the active-site lysine residue of PMRh yields active-site-methylated rhodopsin (AMRh). It had previously been shown, by using AMRh, that the formation of R* and its spectroscopic signature metarhodopsin II requires the photochemically induced deprotonation of the active-site Schiff base [Longstaff, Calhoon & Rando (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 4209-4213]. Here it is demonstrated that active-site Schiff-base deprotonation is also mandatory in the formation of the form of photolyzed rhodopsin that is susceptible to phosphorylation by rhodopsin kinase. In terms of the spectroscopically defined rhodopsin intermediates, this means that only metarhodopsin II and possibly metarhodopsin III are the actual substrates for rhodopsin kinase.
视紫红质对光的吸收会导致一种活化中间体(R*)的形成,该中间体能够催化视网膜鸟嘌呤核苷酸结合调节蛋白(转导蛋白)中GTP与GDP的交换。R作为催化剂的能力会被视紫红质激酶终止。视紫红质的10个非活性位点赖氨酸残基可被还原二甲基化,形成全甲基化视紫红质(PMRh)。这种衍生物在光解后与视紫红质的磷酸化程度相同。PMRh活性位点赖氨酸残基的单甲基化产生活性位点甲基化视紫红质(AMRh)。此前通过使用AMRh已表明,R的形成及其光谱特征视紫红质II需要活性位点席夫碱的光化学诱导去质子化[朗斯塔夫、卡尔洪和兰多(1986年)《美国国家科学院院刊》83, 4209 - 4213]。此处证明,活性位点席夫碱去质子化在形成易被视紫红质激酶磷酸化的光解视紫红质形式中也是必需的。就光谱定义的视紫红质中间体而言,这意味着只有视紫红质II以及可能的视紫红质III是视紫红质激酶的实际底物。